Abciximab Improves Both Epicardial Flow and Myocardial Reperfusion in ST-Elevation Myocardial Infarction
- 25 January 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (3) , 239-243
Abstract
Background —In the presence of ST-elevation myocardial infarction, patients with successful epicardial reperfusion (TIMI 3 flow) but persistent ST elevation on a 12-lead ECG are at high risk for subsequent death and left ventricular dysfunction. In the TIMI 14 trial, a dose-ranging angiographic study, combined therapy with abciximab plus reduced-dose tPA enhanced the speed and efficacy of epicardial reperfusion. We determined whether the combination of abciximab plus reduced-dose tPA provided additional benefit in terms of myocardial reperfusion, as evidenced by greater resolution of ST elevation. Methods and Results —All 346 patients with interpretable baseline and 90-minute ECGs, treated with either tPA alone or abciximab plus reduced-dose tPA (combination therapy), were included. Patients receiving combination therapy (n=221) had a 59% rate of complete (≥70%) ST resolution at 90 minutes versus 37% in those treated with tPA alone (n=125) ( P P =0.0002). Conclusions —Combination therapy with abciximab and reduced-dose tPA improves myocardial (microvascular) reperfusion, as reflected in greater ST-segment resolution, in addition to epicardial flow. This finding may translate into improved clinical outcomes by enhancing myocardial salvage.Keywords
This publication has 20 references indexed in Scilit:
- Assessment of “microvascular no-reflow phenomenon” using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarctionJACC, 1998
- Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarctionThe Lancet, 1997
- Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimensJACC, 1995
- Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1995
- A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agentJACC, 1994
- Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarctionJACC, 1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studiesJACC, 1993
- Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarctionThe American Journal of Cardiology, 1990
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985